MRNA
Price
$107.00
Change
-$1.85 (-1.70%)
Updated
Apr 25, 8:33 AM EST
7 days until earnings call
NVAX
Price
$4.15
Change
-$0.05 (-1.19%)
Updated
Apr 24, 6:59 PM EST
12 days until earnings call
Ad is loading...

Compare predictions MRNA vs NVAX

Header iconMRNA vs NVAX Comparison
Open Charts MRNA vs NVAXBanner chart's image
Moderna
Price$107.00
Change-$1.85 (-1.70%)
Volume$4.46K
CapitalizationN/A
Novavax
Price$4.15
Change-$0.05 (-1.19%)
Volume$1.64M
CapitalizationN/A
View a ticker or compare two or three
MRNA vs NVAX Comparison Chart

Loading...

MRNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
NVAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MRNA vs. NVAX commentary
Apr 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRNA is a Hold and NVAX is a Hold.

COMPARISON
Comparison
Apr 25, 2024
Stock price -- (MRNA: $108.85 vs. NVAX: $4.19)
Brand notoriety: MRNA and NVAX are both notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRNA: 90% vs. NVAX: 48%
Market capitalization -- MRNA: $41.68B vs. NVAX: $580.81M
MRNA [@Biotechnology] is valued at $41.68B. NVAX’s [@Biotechnology] market capitalization is $580.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRNA’s FA Score shows that 1 FA rating(s) are green whileNVAX’s FA Score has 0 green FA rating(s).

  • MRNA’s FA Score: 1 green, 4 red.
  • NVAX’s FA Score: 0 green, 5 red.
According to our system of comparison, MRNA is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRNA’s TA Score shows that 5 TA indicator(s) are bullish while NVAX’s TA Score has 3 bullish TA indicator(s).

  • MRNA’s TA Score: 5 bullish, 1 bearish.
  • NVAX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MRNA is a better buy in the short-term than NVAX.

Price Growth

MRNA (@Biotechnology) experienced а +5.23% price change this week, while NVAX (@Biotechnology) price change was +5.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.16%. For the same industry, the average monthly price growth was -8.48%, and the average quarterly price growth was +1262.76%.

Reported Earning Dates

MRNA is expected to report earnings on Aug 01, 2024.

NVAX is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-1.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MRNA with price predictions.
OPEN
A.I.dvisor published
a Summary for NVAX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MRNA($41.7B) has a higher market cap than NVAX($581M). MRNA YTD gains are higher at: 9.452 vs. NVAX (-13.542).
MRNANVAXMRNA / NVAX
Capitalization41.7B581M7,177%
EBITDAN/AN/A-
Gain YTD9.452-13.542-70%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRNANVAX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
MRNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
NVAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSAFX9.440.01
+0.11%
Hussman Strategic Allocation
FCPIX31.02-0.05
-0.16%
Fidelity Advisor Intl Cap App I
SSTFX11.61-0.03
-0.26%
Virtus KAR Capital Growth C
BIFRX19.16-0.06
-0.31%
BlackRock International R
RPGIX18.83-0.06
-0.32%
T. Rowe Price Global Industrials

NVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVAX has been loosely correlated with THRD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NVAX jumps, then THRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVAX
1D Price
Change %
NVAX100%
-0.95%
THRD - NVAX
42%
Loosely correlated
+2.53%
SYRE - NVAX
38%
Loosely correlated
-3.68%
XNCR - NVAX
38%
Loosely correlated
+3.54%
DNLI - NVAX
36%
Loosely correlated
-3.41%
MRNA - NVAX
35%
Loosely correlated
+0.89%
More